Cerebrolysin vs Pinealon

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Cerebrolysin

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from purified pig brain proteins. It is approved in many countries for stroke, traumatic brain injury, and dementia.

Full details →

Pinealon

Pinealon is a short synthetic peptide developed from research on the pineal gland. It has shown neuroprotective and cognitive-enhancing properties in animal studies.

Full details →

Side-by-Side Comparison

Aspect	Cerebrolysin	Pinealon
Dose Range	2150 mg–4300 mg	5 mg–10 mg
Frequency	1x daily	1x daily
Cycle Length	1–2 weeks	1–2 weeks
Route	intramuscular	subcutaneous
Mechanism	Contains multiple neurotrophic factors that promote neuroplasticity, reduce neuronal apoptosis, and support synaptic function. Has both neurotrophic and neuroprotective properties.	Penetrates cell membranes and interacts with DNA to regulate gene expression related to neuronal survival and function. May support pineal gland function and melatonin production.
Typical Dosage	Clinical dosing: 10-30ml IV daily for acute conditions. Research use: 5-10ml IM daily for cognitive enhancement. Treatment courses typically last 10-20 days.	Typical dosing: 10-20mg daily, taken in divided doses. Often used in cycles of 10-20 days.
Administration	Administered via intramuscular or intravenous injection. IV administration is typically used in clinical settings. IM can be used for research purposes.	Can be taken orally (capsules) or sublingually. Best absorbed on an empty stomach. Often combined with other neuroprotective peptides.
Side Effects	Generally well-tolerated. May cause dizziness, headache, sweating, or injection site reactions. Rare cases of agitation or confusion.	Generally well-tolerated. Limited reported side effects. May affect sleep patterns initially.
Best For	Recovery & Healing Cognitive Performance	Sleep Quality Cognitive Performance